Efficacy and Safety Study of Oral All-trans Retinoic Acid Combined With Toripalimab in Patients With Inoperable Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer Who Had Failed Prior Second-line or Higher Standard Therapy
Latest Information Update: 30 Sep 2024
At a glance
- Drugs Toripalimab (Primary) ; Tretinoin (Primary)
- Indications Advanced breast cancer; Triple negative breast cancer
- Focus Therapeutic Use
Most Recent Events
- 15 Sep 2024 Planned initiation date changed from 1 May 2024 to 15 Oct 2024.
- 19 Apr 2024 New trial record